Parse Biosciences growth playbook

Add a MAX panel to the top of each v4 WT, TCR and BCR page: "Now shipping: Evercode MAX" with a table mapping each v4 kit size to its MAX configuration (samples, cells, cost per sample) and the sizing tool. Rebuild /products/ around MAX, update the footer menu, and decide per page whether to keep it for reorders or redirect it to the matching MAX page. Re-check internal links from the 78 datasets and comparisons.

Launch interest arrives through old URLs; meeting it there turns existing rankings and reorder visits into MAX quotes instead of v4 orders at a higher cost per sample.

[ ] /products/ overview leads with MAX
[ ] Footer menu matches the top menu
[ ] MAX panel and size mapping on WT Mini, WT, Mega, Penta
[ ] MAX panel on TCR and BCR pages
[ ] Sizing tool linked from every kit page
[ ] Dataset and comparison pages link to MAX
[ ] Form pop-up copy filled in (no placeholder text)
[ ] Redirect decision logged for each v4 page

• Existing customers reorder v4 kits

  Keep a clear reorder link on each page while v4 is sold.

• Search rankings drop after redirects

  Redirect only after MAX pages carry the same content and data.

• NewsEvercode MAX press release (October 20, 2026): now shipping; "up to 2.5 times as many cells across up to twice as many samples within their existing budget, or run the same experiment at roughly half the overall cost"; sample barcoding and library prep sold as independent kits; available for Whole Transcriptome, WT FFPE, TCR, BCR and CRISPR Detect; up to 384 samples and 2 million cells; "cost per sample drops by up to 58%"; unused library prep reactions can be saved; same v4 chemistry. Customer quote: "we could essentially do two experiments for the price of one."Source
• Your websiteProduct pages after the MAX launch (checked October 23, 2026): the top menu lists Evercode MAX WT, TCR + WT, BCR + WT and WT FFPE, but the /products/ overview still presents only WT Mini, WT, WT Mega and WT Penta, TCR and BCR; the footer on every page lists Evercode WT Mini, WT, WT Mega, WT Penta, BCR and TCR; and the four v4 WT pages (for example "Evercode WT Penta - 5 Million Single Cell RNA-Seq Kit") are live and in the sitemap, mentioning MAX only in the news ticker.Source
• HiringProduct Manager (Single Cell Sequencing Tech), Seattle or remote US, posted October 15, 2026: will "own current and future products within the Evercode product lines" and their "commercial success", "Coordinate preparation and launch for new product introductions", "Define and refine market positioning for current products", "Develop technical collateral and presentation decks to support sales efforts", and be "the central advocate for the customer internally while proactively building a community externally".Source
• Your websiteEvercode MAX WT page: "build a kit around the number of samples and cells per sample you plan to analyze"; a sizing tool (Number of samples x Cells per sample = Total target cells) that asks for a work email and website to "Get instant pricing", with "Not sure of your numbers? Ask us to help size it."; "In human PBMCs at 40,000 reads per cell, Evercode detected an average of 27.5% more transcripts than Chromium GEM-X Single Cell 3' Kit v4." The same sizing tool sits on the Experiment Planner page. A form pop-up template on these pages still carries placeholder copy ("Test Headline", "Some text goes here").Source

Route sizing requests by total cells: very large studies to GigaLab and business development, growth-account institutions to the Technical Sales Manager, and the rest to territory reps. Reply within a working day with a written MAX configuration (barcoding kit, library prep reactions, sequencing reads) and a booking link with a Field Application Scientist.

A tailored configuration is more useful than a price, and speed decides which vendor a researcher plans the grant or study around.

• Too many small requests

  Small bands get an automated configuration with an optional call.

• Your websiteEvercode MAX WT page: "build a kit around the number of samples and cells per sample you plan to analyze"; a sizing tool (Number of samples x Cells per sample = Total target cells) that asks for a work email and website to "Get instant pricing", with "Not sure of your numbers? Ask us to help size it."; "In human PBMCs at 40,000 reads per cell, Evercode detected an average of 27.5% more transcripts than Chromium GEM-X Single Cell 3' Kit v4." The same sizing tool sits on the Experiment Planner page. A form pop-up template on these pages still carries placeholder copy ("Test Headline", "Some text goes here").Source
• HiringTechnical Sales Manager - Growth Accounts (US Overlay), remote US, posted September 22, 2026: will "accelerate growth in both named Key Accounts and select territories", "act as a specialist to move an emerging segment faster than one rep can on their own", "Prioritize and qualify inbound leads", "Develop, maintain, and grow repeat business", "Negotiate and close deals while minimizing discounting", and work with Field Application Scientists and "prospecting specialists".Source
• Your websiteGigaLab: "greater than 10M cells in a single run", capacity "to analyze 2.5B cells per year", barcoding and library prep of "10M cells across up to 1,152 samples taking less than 3 days"; programs with Tahoe (Vevo Therapeutics, a 100M-cell atlas for AI drug discovery), Mount Sinai and Helmholtz Munich. The page says the average single cell count in publications "is doubling each year". The commercial licensing page offers datasets such as a 10 million human PBMC screen with 90 cytokine treatments and says "New large-scale drug perturbation datasets are in progress".Source
• Google PageSpeedHomepage mobile lab test: performance 55 (desktop 77), first content at 11.6 s and Largest Contentful Paint 16.6 s (the hero image), with about 3.7 s of render-blocking requests and 495 KB of unused JavaScript; page weight 2.5 MB in 144 requests, of which the meeting scheduler (Chili Piper) loads 975 KB in 40 requests. Real Chrome users pass Core Web Vitals: LCP 2.4 s, INP 126 ms, CLS 0.07. Lighthouse also flags no valid hreflang and 16 images without alt text.Source

Lead the comparisons page with the v4 data, add a cost-per-sample view at MAX configurations, run one new head-to-head on a hard sample type (FFPE or whole blood), and turn each into a two-page sales PDF.

Evaluators and procurement compare the latest kits; current data shortens the evaluation and arms the sales team.

• Comparison claims challenged

  Publish methods and raw data, as today.

• Your websiteCompetitive comparisons page ("The Data Doesn't Lie"): every head-to-head listed uses Evercode WT v3 (vs Chromium GEM-X v4, Chromium Flex and Chromium Next GEM v3.1), one chemistry version behind the v4 chemistry that MAX runs on.Source
• Your websiteEvercode MAX WT page: "build a kit around the number of samples and cells per sample you plan to analyze"; a sizing tool (Number of samples x Cells per sample = Total target cells) that asks for a work email and website to "Get instant pricing", with "Not sure of your numbers? Ask us to help size it."; "In human PBMCs at 40,000 reads per cell, Evercode detected an average of 27.5% more transcripts than Chromium GEM-X Single Cell 3' Kit v4." The same sizing tool sits on the Experiment Planner page. A form pop-up template on these pages still carries placeholder copy ("Test Headline", "Some text goes here").Source
• HiringProduct Manager (Single Cell Sequencing Tech), Seattle or remote US, posted October 15, 2026: will "own current and future products within the Evercode product lines" and their "commercial success", "Coordinate preparation and launch for new product introductions", "Define and refine market positioning for current products", "Develop technical collateral and presentation decks to support sales efforts", and be "the central advocate for the customer internally while proactively building a community externally".Source
• Competitor researchParse's own comparisons are against 10x Genomics Chromium kits (GEM-X v4, Flex, Next GEM). Fluent BioSciences' PIPseeker software now analyzes "Illumina 3' Single Cell RNA Prep" libraries, i.e. the instrument-free droplet alternative is sold by Illumina. BD Rhapsody and Scale Biosciences also sell high-throughput single cell kits.See the research Source

Let the tool show the configuration straight away (kits, reactions, total reads at 10,000 reads per cell, which matches the planner) and offer the price and a saved PDF for the email. Test the change against the current gate.

Showing value first raises completion, and researchers who come back for the price are better leads.

• Fewer emails captured

  Judge by quotes and orders, not form fills.

• Your websiteEvercode MAX WT page: "build a kit around the number of samples and cells per sample you plan to analyze"; a sizing tool (Number of samples x Cells per sample = Total target cells) that asks for a work email and website to "Get instant pricing", with "Not sure of your numbers? Ask us to help size it."; "In human PBMCs at 40,000 reads per cell, Evercode detected an average of 27.5% more transcripts than Chromium GEM-X Single Cell 3' Kit v4." The same sizing tool sits on the Experiment Planner page. A form pop-up template on these pages still carries placeholder copy ("Test Headline", "Some text goes here").Source
• NewsEvercode MAX press release (October 20, 2026): now shipping; "up to 2.5 times as many cells across up to twice as many samples within their existing budget, or run the same experiment at roughly half the overall cost"; sample barcoding and library prep sold as independent kits; available for Whole Transcriptome, WT FFPE, TCR, BCR and CRISPR Detect; up to 384 samples and 2 million cells; "cost per sample drops by up to 58%"; unused library prep reactions can be saved; same v4 chemistry. Customer quote: "we could essentially do two experiments for the price of one."Source
• HiringTechnical Sales Manager - Growth Accounts (US Overlay), remote US, posted September 22, 2026: will "accelerate growth in both named Key Accounts and select territories", "act as a specialist to move an emerging segment faster than one rep can on their own", "Prioritize and qualify inbound leads", "Develop, maintain, and grow repeat business", "Negotiate and close deals while minimizing discounting", and work with Field Application Scientists and "prospecting specialists".Source

Load the scheduler on click of a booking button, defer HubSpot chat until interaction, inline critical CSS and remove unused JavaScript. Set a page-weight budget for templates.

Researchers browse on phones at conferences and between experiments; a faster first view keeps them reading the data.

• Booking flow breaks

  Test on all forms before release.

• Google PageSpeedHomepage mobile lab test: performance 55 (desktop 77), first content at 11.6 s and Largest Contentful Paint 16.6 s (the hero image), with about 3.7 s of render-blocking requests and 495 KB of unused JavaScript; page weight 2.5 MB in 144 requests, of which the meeting scheduler (Chili Piper) loads 975 KB in 40 requests. Real Chrome users pass Core Web Vitals: LCP 2.4 s, INP 126 ms, CLS 0.07. Lighthouse also flags no valid hreflang and 16 images without alt text.Source

Add hreflang (en, ja, x-default) on every page through the translation plugin, check the Japanese MAX pages are translated, and route Japanese quote requests to the distributor.

Correct language targeting is a small fix that sends local searchers to local pages and partners.

• Machine translation errors

  Distributor review.

• Google PageSpeedHomepage mobile lab test: performance 55 (desktop 77), first content at 11.6 s and Largest Contentful Paint 16.6 s (the hero image), with about 3.7 s of render-blocking requests and 495 KB of unused JavaScript; page weight 2.5 MB in 144 requests, of which the meeting scheduler (Chili Piper) loads 975 KB in 40 requests. Real Chrome users pass Core Web Vitals: LCP 2.4 s, INP 126 ms, CLS 0.07. Lighthouse also flags no valid hreflang and 16 images without alt text.Source
• Your websiteChannels: Certified Service Providers include Xpress Genomics (Stockholm, since 2026), Garvan Genomics Platform (New South Wales, since 2026), the South Australian Genomics Centre and SeqMatic (California), each certified for specific kits (e.g. Evercode WT, TCR, BCR, CRISPR Detect); distributors in India, Japan, Colombia, Taiwan and Southeast Asia. The site has a Japanese version.Source

Build a pharma page and one-pager: pilot package (for example one perturbation screen), timeline from sample receipt to data, data ownership and confidentiality terms, and QIAGEN-backed quality. Run account-based outreach to drug-discovery teams.

Pharma buys on risk reduction; a defined pilot turns interest into a first contract.

• Pilots do not convert

  Agree the follow-on scope at signing.

• HiringDirector, Business Development (Genomics), US, UK or EU, posted August 10, 2026: will expand "partnerships with pharmaceutical and biotechnology companies worldwide" and "drive revenue growth for Parse's GigaLab services business and custom solutions", owning deals "from initial customer engagement through proposal development, contract negotiation, and successful close".Source
• Your websiteGigaLab: "greater than 10M cells in a single run", capacity "to analyze 2.5B cells per year", barcoding and library prep of "10M cells across up to 1,152 samples taking less than 3 days"; programs with Tahoe (Vevo Therapeutics, a 100M-cell atlas for AI drug discovery), Mount Sinai and Helmholtz Munich. The page says the average single cell count in publications "is doubling each year". The commercial licensing page offers datasets such as a 10 million human PBMC screen with 90 cytokine treatments and says "New large-scale drug perturbation datasets are in progress".Source
• NewsParse joined QIAGEN (announced November 4, 2025): "To our first 3,000 customers ..."; "We're excited to now be able to offer our products to the 500,000 labs that the wider QIAGEN team serves". The homepage now says "Advancing Research for 3,500+ Labs".Source

Offer an annual data subscription: current catalogue plus each new perturbation dataset on release, in model-ready formats, with an option to commission a custom screen in GigaLab.

Subscriptions turn one-off licenses into recurring revenue and feed GigaLab with custom projects.

• Release delays

  Commit to a minimum yearly volume.

• Your websiteGigaLab: "greater than 10M cells in a single run", capacity "to analyze 2.5B cells per year", barcoding and library prep of "10M cells across up to 1,152 samples taking less than 3 days"; programs with Tahoe (Vevo Therapeutics, a 100M-cell atlas for AI drug discovery), Mount Sinai and Helmholtz Munich. The page says the average single cell count in publications "is doubling each year". The commercial licensing page offers datasets such as a 10 million human PBMC screen with 90 cytokine treatments and says "New large-scale drug perturbation datasets are in progress".Source
• HiringDirector, Business Development (Genomics), US, UK or EU, posted August 10, 2026: will expand "partnerships with pharmaceutical and biotechnology companies worldwide" and "drive revenue growth for Parse's GigaLab services business and custom solutions", owning deals "from initial customer engagement through proposal development, contract negotiation, and successful close".Source

Give each project a status page: samples received, QC, barcoding, sequencing, data delivered, with dates and the next step, and a weekly summary email.

Visibility cuts status emails and builds the trust that wins the next, larger project.

• Delays become visible

  Explain them early with a new date.

• HiringDirector, GigaLab & Genomics Services (Seattle, posted August 11, 2026) will "lead and scale the GigaLab", a "growing, revenue-generating function", owning customer programs "from onboarding through delivery" with capacity planning and on-time delivery. A Head of Operations (posted August 12, 2026) will lead the Seattle manufacturing site and "Support/manage facility, processes and personnel to support significant growth".Source
• Your websiteGigaLab: "greater than 10M cells in a single run", capacity "to analyze 2.5B cells per year", barcoding and library prep of "10M cells across up to 1,152 samples taking less than 3 days"; programs with Tahoe (Vevo Therapeutics, a 100M-cell atlas for AI drug discovery), Mount Sinai and Helmholtz Munich. The page says the average single cell count in publications "is doubling each year". The commercial licensing page offers datasets such as a 10 million human PBMC screen with 90 cytokine treatments and says "New large-scale drug perturbation datasets are in progress".Source

Flag accounts with a Mini order in the last 12 months, send their FAS a MAX configuration sized to a full study, and offer a planning call with a cost-per-sample comparison.

The next purchase is the biggest one, and the account already trusts the chemistry.

• Labs lack budget

  Pair with the grant kit idea.

• Your websiteSitemap (602 URLs, checked October 23, 2026): 84 news items (latest October 20), 78 datasets, about 40 blog posts with the feed's last post on August 18, 2026 ("Funding Large Scale scRNA-seq Research"); the WT Mini page positions it to "Generate proof-of-concept results before you scale up to the Evercode WT or Evercode WT Mega". Every kit includes Trailmaker analysis software.Source
• HiringTechnical Sales Manager - Growth Accounts (US Overlay), remote US, posted September 22, 2026: will "accelerate growth in both named Key Accounts and select territories", "act as a specialist to move an emerging segment faster than one rep can on their own", "Prioritize and qualify inbound leads", "Develop, maintain, and grow repeat business", "Negotiate and close deals while minimizing discounting", and work with Field Application Scientists and "prospecting specialists".Source
• NewsEvercode MAX press release (October 20, 2026): now shipping; "up to 2.5 times as many cells across up to twice as many samples within their existing budget, or run the same experiment at roughly half the overall cost"; sample barcoding and library prep sold as independent kits; available for Whole Transcriptome, WT FFPE, TCR, BCR and CRISPR Detect; up to 384 samples and 2 million cells; "cost per sample drops by up to 58%"; unused library prep reactions can be saved; same v4 chemistry. Customer quote: "we could essentially do two experiments for the price of one."Source

Start a quarterly online user meeting with two customer talks, a forum inside the support suite, and a published list of new Evercode papers each month.

Peer advice reduces support load and makes the switch from droplets feel safe for new labs.

• Low activity

  Seed with FAS posts.

• HiringProduct Manager (Single Cell Sequencing Tech), Seattle or remote US, posted October 15, 2026: will "own current and future products within the Evercode product lines" and their "commercial success", "Coordinate preparation and launch for new product introductions", "Define and refine market positioning for current products", "Develop technical collateral and presentation decks to support sales efforts", and be "the central advocate for the customer internally while proactively building a community externally".Source
• NewsParse joined QIAGEN (announced November 4, 2025): "To our first 3,000 customers ..."; "We're excited to now be able to offer our products to the 500,000 labs that the wider QIAGEN team serves". The homepage now says "Advancing Research for 3,500+ Labs".Source
• Your websiteSitemap (602 URLs, checked October 23, 2026): 84 news items (latest October 20), 78 datasets, about 40 blog posts with the feed's last post on August 18, 2026 ("Funding Large Scale scRNA-seq Research"); the WT Mini page positions it to "Generate proof-of-concept results before you scale up to the Evercode WT or Evercode WT Mega". Every kit includes Trailmaker analysis software.Source

Run a fast MAX certification for existing providers, add a map with each provider's certified MAX assays and turnaround, and route quote requests from labs that want a service to the nearest provider.

Providers extend reach without adding Parse headcount, and a map turns the list into a buying path.

• Quality variation

  Keep certification runs strict.

• Your websiteChannels: Certified Service Providers include Xpress Genomics (Stockholm, since 2026), Garvan Genomics Platform (New South Wales, since 2026), the South Australian Genomics Centre and SeqMatic (California), each certified for specific kits (e.g. Evercode WT, TCR, BCR, CRISPR Detect); distributors in India, Japan, Colombia, Taiwan and Southeast Asia. The site has a Japanese version.Source
• NewsEvercode MAX press release (October 20, 2026): now shipping; "up to 2.5 times as many cells across up to twice as many samples within their existing budget, or run the same experiment at roughly half the overall cost"; sample barcoding and library prep sold as independent kits; available for Whole Transcriptome, WT FFPE, TCR, BCR and CRISPR Detect; up to 384 samples and 2 million cells; "cost per sample drops by up to 58%"; unused library prep reactions can be saved; same v4 chemistry. Customer quote: "we could essentially do two experiments for the price of one."Source

Train a group of QIAGEN specialists on Evercode MAX, publish a joint sample-to-insight workflow, list Parse kits in QIAGEN's ordering channels, and run joint webinars for QIAGEN customer segments.

The parent company's channels are the cheapest new reach available, and a joint workflow makes the purchase simple.

• Channel conflict

  Agree rules for lead ownership.

• NewsParse joined QIAGEN (announced November 4, 2025): "To our first 3,000 customers ..."; "We're excited to now be able to offer our products to the 500,000 labs that the wider QIAGEN team serves". The homepage now says "Advancing Research for 3,500+ Labs".Source
• NewsEvercode MAX press release (October 20, 2026): now shipping; "up to 2.5 times as many cells across up to twice as many samples within their existing budget, or run the same experiment at roughly half the overall cost"; sample barcoding and library prep sold as independent kits; available for Whole Transcriptome, WT FFPE, TCR, BCR and CRISPR Detect; up to 384 samples and 2 million cells; "cost per sample drops by up to 58%"; unused library prep reactions can be saved; same v4 chemistry. Customer quote: "we could essentially do two experiments for the price of one."Source
• HiringTechnical Sales Manager - Growth Accounts (US Overlay), remote US, posted September 22, 2026: will "accelerate growth in both named Key Accounts and select territories", "act as a specialist to move an emerging segment faster than one rep can on their own", "Prioritize and qualify inbound leads", "Develop, maintain, and grow repeat business", "Negotiate and close deals while minimizing discounting", and work with Field Application Scientists and "prospecting specialists".Source

Publish a grant kit: budget justification text, a cost-per-sample table at common study sizes, methods text, a letter of support request, and example sequencing budgets. Offer it from the sizing tool and send it to leads before major grant deadlines.

Being written into the grant decides the purchase long before procurement.

• Prices change

  Date the table.

• Your websiteSitemap (602 URLs, checked October 23, 2026): 84 news items (latest October 20), 78 datasets, about 40 blog posts with the feed's last post on August 18, 2026 ("Funding Large Scale scRNA-seq Research"); the WT Mini page positions it to "Generate proof-of-concept results before you scale up to the Evercode WT or Evercode WT Mega". Every kit includes Trailmaker analysis software.Source
• NewsEvercode MAX press release (October 20, 2026): now shipping; "up to 2.5 times as many cells across up to twice as many samples within their existing budget, or run the same experiment at roughly half the overall cost"; sample barcoding and library prep sold as independent kits; available for Whole Transcriptome, WT FFPE, TCR, BCR and CRISPR Detect; up to 384 samples and 2 million cells; "cost per sample drops by up to 58%"; unused library prep reactions can be saved; same v4 chemistry. Customer quote: "we could essentially do two experiments for the price of one."Source
• Your websiteEvercode MAX WT page: "build a kit around the number of samples and cells per sample you plan to analyze"; a sizing tool (Number of samples x Cells per sample = Total target cells) that asks for a work email and website to "Get instant pricing", with "Not sure of your numbers? Ask us to help size it."; "In human PBMCs at 40,000 reads per cell, Evercode detected an average of 27.5% more transcripts than Chromium GEM-X Single Cell 3' Kit v4." The same sizing tool sits on the Experiment Planner page. A form pop-up template on these pages still carries placeholder copy ("Test Headline", "Some text goes here").Source

Show each lab its unused reactions in the customer portal and send a reminder with a suggested next experiment and the matching barcoding kit before they would expire.

Saved reactions are a reason to run the next study with Parse rather than a competitor.

• Incomplete usage data

  Ask labs to confirm in the portal.

• NewsEvercode MAX press release (October 20, 2026): now shipping; "up to 2.5 times as many cells across up to twice as many samples within their existing budget, or run the same experiment at roughly half the overall cost"; sample barcoding and library prep sold as independent kits; available for Whole Transcriptome, WT FFPE, TCR, BCR and CRISPR Detect; up to 384 samples and 2 million cells; "cost per sample drops by up to 58%"; unused library prep reactions can be saved; same v4 chemistry. Customer quote: "we could essentially do two experiments for the price of one."Source
• Your websiteEvercode MAX WT page: "build a kit around the number of samples and cells per sample you plan to analyze"; a sizing tool (Number of samples x Cells per sample = Total target cells) that asks for a work email and website to "Get instant pricing", with "Not sure of your numbers? Ask us to help size it."; "In human PBMCs at 40,000 reads per cell, Evercode detected an average of 27.5% more transcripts than Chromium GEM-X Single Cell 3' Kit v4." The same sizing tool sits on the Experiment Planner page. A form pop-up template on these pages still carries placeholder copy ("Test Headline", "Some text goes here").Source

Add an "Explore in Trailmaker" button to every dataset page, with a light sign-up, and follow up with a sizing suggestion based on the dataset viewed.

Hands-on exploration is the best proof, and the dataset viewed tells sales what the researcher studies.

• Compute costs

  Pre-processed data only.

• Your websiteSitemap (602 URLs, checked October 23, 2026): 84 news items (latest October 20), 78 datasets, about 40 blog posts with the feed's last post on August 18, 2026 ("Funding Large Scale scRNA-seq Research"); the WT Mini page positions it to "Generate proof-of-concept results before you scale up to the Evercode WT or Evercode WT Mega". Every kit includes Trailmaker analysis software.Source
• Your websiteGigaLab: "greater than 10M cells in a single run", capacity "to analyze 2.5B cells per year", barcoding and library prep of "10M cells across up to 1,152 samples taking less than 3 days"; programs with Tahoe (Vevo Therapeutics, a 100M-cell atlas for AI drug discovery), Mount Sinai and Helmholtz Munich. The page says the average single cell count in publications "is doubling each year". The commercial licensing page offers datasets such as a 10 million human PBMC screen with 90 cytokine treatments and says "New large-scale drug perturbation datasets are in progress".Source

Show a confirmed ship window on each quote and order confirmation, based on stock of barcoding and library prep kits, and alert sales early if a module runs short.

A dependable date removes a reason to delay and protects the launch's reputation.

• Missed dates

  Quote conservative windows.

• HiringDirector, GigaLab & Genomics Services (Seattle, posted August 11, 2026) will "lead and scale the GigaLab", a "growing, revenue-generating function", owning customer programs "from onboarding through delivery" with capacity planning and on-time delivery. A Head of Operations (posted August 12, 2026) will lead the Seattle manufacturing site and "Support/manage facility, processes and personnel to support significant growth".Source
• NewsEvercode MAX press release (October 20, 2026): now shipping; "up to 2.5 times as many cells across up to twice as many samples within their existing budget, or run the same experiment at roughly half the overall cost"; sample barcoding and library prep sold as independent kits; available for Whole Transcriptome, WT FFPE, TCR, BCR and CRISPR Detect; up to 384 samples and 2 million cells; "cost per sample drops by up to 58%"; unused library prep reactions can be saved; same v4 chemistry. Customer quote: "we could essentially do two experiments for the price of one."Source

Form a consortium: members fund a large shared perturbation atlas produced in GigaLab, get early access and influence on design, and can commission private extensions. Publish a public subset for the field.

Shared funding fills GigaLab capacity, gives Parse the reference dataset of the field, and creates long relationships with each member.

• Slow consortium decisions

  Parse sets the design; members choose options.

• Your websiteGigaLab: "greater than 10M cells in a single run", capacity "to analyze 2.5B cells per year", barcoding and library prep of "10M cells across up to 1,152 samples taking less than 3 days"; programs with Tahoe (Vevo Therapeutics, a 100M-cell atlas for AI drug discovery), Mount Sinai and Helmholtz Munich. The page says the average single cell count in publications "is doubling each year". The commercial licensing page offers datasets such as a 10 million human PBMC screen with 90 cytokine treatments and says "New large-scale drug perturbation datasets are in progress".Source
• HiringDirector, Business Development (Genomics), US, UK or EU, posted August 10, 2026: will expand "partnerships with pharmaceutical and biotechnology companies worldwide" and "drive revenue growth for Parse's GigaLab services business and custom solutions", owning deals "from initial customer engagement through proposal development, contract negotiation, and successful close".Source
• NewsParse joined QIAGEN (announced November 4, 2025): "To our first 3,000 customers ..."; "We're excited to now be able to offer our products to the 500,000 labs that the wider QIAGEN team serves". The homepage now says "Advancing Research for 3,500+ Labs".Source

Build an FFPE program: biobank-specific page, a pilot with one cancer center, a workflow with pathology, and outreach to translational research groups.

Archived tissue with outcomes is unique data; first-mover vendors become the standard for those groups.

• Long sales cycles

  Start with research-funded groups.

• Your websiteProduct pages after the MAX launch (checked October 23, 2026): the top menu lists Evercode MAX WT, TCR + WT, BCR + WT and WT FFPE, but the /products/ overview still presents only WT Mini, WT, WT Mega and WT Penta, TCR and BCR; the footer on every page lists Evercode WT Mini, WT, WT Mega, WT Penta, BCR and TCR; and the four v4 WT pages (for example "Evercode WT Penta - 5 Million Single Cell RNA-Seq Kit") are live and in the sitemap, mentioning MAX only in the news ticker.Source
• NewsEvercode MAX press release (October 20, 2026): now shipping; "up to 2.5 times as many cells across up to twice as many samples within their existing budget, or run the same experiment at roughly half the overall cost"; sample barcoding and library prep sold as independent kits; available for Whole Transcriptome, WT FFPE, TCR, BCR and CRISPR Detect; up to 384 samples and 2 million cells; "cost per sample drops by up to 58%"; unused library prep reactions can be saved; same v4 chemistry. Customer quote: "we could essentially do two experiments for the price of one."Source
• Your websiteChannels: Certified Service Providers include Xpress Genomics (Stockholm, since 2026), Garvan Genomics Platform (New South Wales, since 2026), the South Australian Genomics Centre and SeqMatic (California), each certified for specific kits (e.g. Evercode WT, TCR, BCR, CRISPR Detect); distributors in India, Japan, Colombia, Taiwan and Southeast Asia. The site has a Japanese version.Source

Offer cores a program: certification, volume pricing, co-branded materials and training, and list them on the provider map.

One core can bring dozens of labs; cores are where droplet platforms are entrenched.

• Price pressure

  Tie pricing to volume commitments.

• Your websiteChannels: Certified Service Providers include Xpress Genomics (Stockholm, since 2026), Garvan Genomics Platform (New South Wales, since 2026), the South Australian Genomics Centre and SeqMatic (California), each certified for specific kits (e.g. Evercode WT, TCR, BCR, CRISPR Detect); distributors in India, Japan, Colombia, Taiwan and Southeast Asia. The site has a Japanese version.Source
• HiringTechnical Sales Manager - Growth Accounts (US Overlay), remote US, posted September 22, 2026: will "accelerate growth in both named Key Accounts and select territories", "act as a specialist to move an emerging segment faster than one rep can on their own", "Prioritize and qualify inbound leads", "Develop, maintain, and grow repeat business", "Negotiate and close deals while minimizing discounting", and work with Field Application Scientists and "prospecting specialists".Source
• Your websiteSitemap (602 URLs, checked October 23, 2026): 84 news items (latest October 20), 78 datasets, about 40 blog posts with the feed's last post on August 18, 2026 ("Funding Large Scale scRNA-seq Research"); the WT Mini page positions it to "Generate proof-of-concept results before you scale up to the Evercode WT or Evercode WT Mega". Every kit includes Trailmaker analysis software.Source

Track new single cell papers each quarter, publish median cells and samples per study by field and method, and show where MAX and GigaLab fit.

Original data earns citations and keeps the scale message current.

• Selection bias

  Publish the method.

• Your websiteGigaLab: "greater than 10M cells in a single run", capacity "to analyze 2.5B cells per year", barcoding and library prep of "10M cells across up to 1,152 samples taking less than 3 days"; programs with Tahoe (Vevo Therapeutics, a 100M-cell atlas for AI drug discovery), Mount Sinai and Helmholtz Munich. The page says the average single cell count in publications "is doubling each year". The commercial licensing page offers datasets such as a 10 million human PBMC screen with 90 cytokine treatments and says "New large-scale drug perturbation datasets are in progress".Source
• Your websiteSitemap (602 URLs, checked October 23, 2026): 84 news items (latest October 20), 78 datasets, about 40 blog posts with the feed's last post on August 18, 2026 ("Funding Large Scale scRNA-seq Research"); the WT Mini page positions it to "Generate proof-of-concept results before you scale up to the Evercode WT or Evercode WT Mega". Every kit includes Trailmaker analysis software.Source

Run a monthly 30-minute session where a MAX customer explains how they chose samples versus cells, their cost and their first data, then post short clips.

Real study design choices answer the questions buyers bring to sales.

• Few early customers

  Start with internal case studies.

• NewsEvercode MAX press release (October 20, 2026): now shipping; "up to 2.5 times as many cells across up to twice as many samples within their existing budget, or run the same experiment at roughly half the overall cost"; sample barcoding and library prep sold as independent kits; available for Whole Transcriptome, WT FFPE, TCR, BCR and CRISPR Detect; up to 384 samples and 2 million cells; "cost per sample drops by up to 58%"; unused library prep reactions can be saved; same v4 chemistry. Customer quote: "we could essentially do two experiments for the price of one."Source
• HiringProduct Manager (Single Cell Sequencing Tech), Seattle or remote US, posted October 15, 2026: will "own current and future products within the Evercode product lines" and their "commercial success", "Coordinate preparation and launch for new product introductions", "Define and refine market positioning for current products", "Develop technical collateral and presentation decks to support sales efforts", and be "the central advocate for the customer internally while proactively building a community externally".Source